Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks

We assessed metabolic changes for darunavir/ritonavir (DRV/r) once daily (qd) versus atazanavir/ritonavir (ATV/r) qd with fixed-dose tenofovir/emtricitabine. This was a phase 4, multicenter, open-label, randomized exploratory study. Treatment-naive, HIV-1-infected adults received DRV/r 800/100 mg qd...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Aberg, Judith A., Tebas, Pablo, Overton, Edgar Turner, Gupta, Samir K., Sax, Paul E., Landay, Alan, Falcon, Ron, Ryan, Robert, De La Rosa, Guy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc. 2012
Konular:
Clinical Trials/Clinical Studies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3448095/
https://ncbi.nlm.nih.gov/pubmed/22352336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2011.0327
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller